{"entity":{"type":"insider","cik":"0001293928","url":"/insider/0001293928","json_url":"/insider/0001293928.json","name":"Rosch Thomas L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":8,"first":"2004-06-23","last":"2012-07-05","span_basis":"filed_date"},"name_variants":[{"name":"Rosch Thomas L","source":"filing","n_filings":8,"first_seen":"2004-06-23","last_seen":"2012-07-05"}],"transactions":[{"id":2162167,"accession":"0001209191-12-037464","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-037464","line_url":"/filing/0001209191-12-037464#line-2","is_derivative":false,"issuer_cik":"0001198704","issuer_name":"TESARO, Inc.","issuer_ticker":"TSRO","issuer_name_source":null,"issuer_url":"/issuer/0001198704","owner_cik":null,"owner_name":"Holmes W Stephen; CLEVELAND BRUCE A; INTERWEST PARTNERS X LP; GIANOS PHILIP T; Pepper Douglas A; Kliman Gilbert H; Rosch Thomas L; CASH HARVEY B; Ehrlich Christopher B; Kjellson Nina S","owner_display_name":"Holmes W Stephen","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":444444.0,"shares_display":"444,444","price_per_share":13.5,"price_display":"13.50","price_state":"stated","total_value":5999994.0,"total_display":"5,999,994.00","total_whole":"5,999,994","shares_owned_after":3071701.0,"shares_owned_after_display":"3,071,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-03","filed_date":"2012-07-05","scope":"insider"},{"id":9193446,"accession":"0001209191-11-048898","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-048898","line_url":"/filing/0001209191-11-048898#line-1","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Transcept Pharmaceuticals Inc","issuer_ticker":"TSPT","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":null,"owner_name":"Rosch Thomas L; Pepper Douglas A; ORONSKY ARNOLD L; NASR KHALED; InterWest Partners IX, LP; CLEVELAND BRUCE A; GIANOS PHILIP T; CASH HARVEY B; Holmes W Stephen; Kliman Gilbert H","owner_display_name":"Rosch Thomas L","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":217228.0,"shares_display":"217,228","price_per_share":7.2418,"price_display":"7.24","price_state":"stated","total_value":1573121.7304,"total_display":"1,573,121.73","total_whole":"1,573,122","shares_owned_after":1983884.0,"shares_owned_after_display":"1,983,884","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-21","filed_date":"2011-09-23","scope":"insider"},{"id":8823126,"accession":"0001104659-11-005370","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001104659-11-005370","line_url":"/filing/0001104659-11-005370","is_derivative":false,"issuer_cik":"0001081735","issuer_name":"EPOCRATES INC","issuer_ticker":"EPOC","issuer_name_source":null,"issuer_url":"/issuer/0001081735","owner_cik":null,"owner_name":"INTERWEST MANAGEMENT PARTNERS VII LLC; Holmes W Stephen; INTERWEST PARTNERS VII L P; GIANOS PHILIP T; Rosch Thomas L; InterWest Investors VII, LP; HEDRICK W SCOTT; ORONSKY ARNOLD L; CASH HARVEY B","owner_display_name":"INTERWEST MANAGEMENT PARTNERS VII LLC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":426223.0,"shares_display":"426,223","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":6819568.0,"total_display":"6,819,568.00","total_whole":"6,819,568","shares_owned_after":1885124.0,"shares_owned_after_display":"1,885,124","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-07","filed_date":"2011-02-07","scope":"insider","n_lines":2},{"id":7386777,"accession":"0001181431-10-041126","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-10-041126","line_url":"/filing/0001181431-10-041126#line-3","is_derivative":false,"issuer_cik":"0001198704","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001198704","owner_cik":null,"owner_name":"CLEVELAND BRUCE A; Holmes W Stephen; InterWest Partners IX, LP; CASH HARVEY B; ORONSKY ARNOLD L; Kliman Gilbert H; Rosch Thomas L; GIANOS PHILIP T; InterWest Management Partners IX, LLC; SWEENEY MICHAEL B","owner_display_name":"CLEVELAND BRUCE A","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1227333.0,"shares_display":"1,227,333","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":6136665.0,"total_display":"6,136,665.00","total_whole":"6,136,665","shares_owned_after":3548643.0,"shares_owned_after_display":"3,548,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-06","filed_date":"2010-08-10","scope":"insider"},{"id":3710821,"accession":"0001209191-08-024799","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-024799","line_url":"/filing/0001209191-08-024799","is_derivative":false,"issuer_cik":"0001053221","issuer_name":"METABASIS THERAPEUTICS INC","issuer_ticker":"MBRX","issuer_name_source":null,"issuer_url":"/issuer/0001053221","owner_cik":null,"owner_name":"Holmes W Stephen; INTERWEST MANAGEMENT PARTNERS VII LLC; Rosch Thomas L; GIANOS PHILIP T; INTERWEST PARTNERS VII L P; InterWest Investors VII, LP; CASH HARVEY B; Kliman Gilbert H; HEDRICK W SCOTT","owner_display_name":"Holmes W Stephen","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":990816.0,"shares_display":"990,816","price_per_share":2.34,"price_display":"2.34","price_state":"stated","total_value":2318509.44,"total_display":"2,318,509.44","total_whole":"2,318,509","shares_owned_after":3456030.0,"shares_owned_after_display":"3,456,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-04-16","filed_date":"2008-04-18","scope":"insider","n_lines":2},{"id":7085753,"accession":"0001209191-07-065051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-065051","line_url":"/filing/0001209191-07-065051#line-1","is_derivative":false,"issuer_cik":"0000902215","issuer_name":"EnteroMedics Inc","issuer_ticker":"ETRM","issuer_name_source":null,"issuer_url":"/issuer/0000902215","owner_cik":null,"owner_name":"Kliman Gilbert H; InterWest Partners IX, LP; Holmes W Stephen; BOICH MICHAEL D; GIANOS PHILIP T; CLEVELAND BRUCE A; SWEENEY MICHAEL B; ORONSKY ARNOLD L; CASH HARVEY B; Rosch Thomas L","owner_display_name":"Kliman Gilbert H","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":187500.0,"shares_display":"187,500","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":1500000.0,"total_display":"1,500,000.00","total_whole":"1,500,000","shares_owned_after":187500.0,"shares_owned_after_display":"187,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-15","filed_date":"2007-11-19","scope":"insider"},{"id":1400284,"accession":"0001209191-05-050703","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-05-050703","line_url":"/filing/0001209191-05-050703","is_derivative":false,"issuer_cik":"0001053221","issuer_name":"METABASIS THERAPEUTICS INC","issuer_ticker":"MBRX","issuer_name_source":null,"issuer_url":"/issuer/0001053221","owner_cik":null,"owner_name":"CASH HARVEY B; Kliman Gilbert H; Holmes W Stephen; Bowsher Stephen C; INTERWEST PARTNERS VII L P; HEDRICK W SCOTT; GIANOS PHILIP T; InterWest Investors VII, LP; INTERWEST MANAGEMENT PARTNERS VII LLC; Rosch Thomas L","owner_display_name":"CASH HARVEY B","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":426621.0,"shares_display":"426,621","price_per_share":5.86,"price_display":"5.86","price_state":"stated","total_value":2499999.06,"total_display":"2,499,999.06","total_whole":"2,499,999","shares_owned_after":2510453.0,"shares_owned_after_display":"2,510,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-09-30","filed_date":"2005-10-04","scope":"insider","n_lines":2},{"id":327999,"accession":"0001179044-04-000258","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179044-04-000258","line_url":"/filing/0001179044-04-000258","is_derivative":false,"issuer_cik":"0001053221","issuer_name":"METABASIS THERAPEUTICS INC","issuer_ticker":"MBRX","issuer_name_source":null,"issuer_url":"/issuer/0001053221","owner_cik":null,"owner_name":"INTERWEST PARTNERS VII L P; Rosch Thomas L","owner_display_name":"INTERWEST PARTNERS VII L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":130000.0,"shares_display":"130,000","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":910000.0,"total_display":"910,000.00","total_whole":"910,000","shares_owned_after":124059.0,"shares_owned_after_display":"124,059","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-06-21","filed_date":"2004-06-23","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001491576","name":"TESARO, Inc.","url":"/issuer/0001491576","role":"Ten percent owner","n_filings":1,"first_seen":"2012-07-05","last_seen":"2012-07-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001178711","name":"Transcept Pharmaceuticals Inc","url":"/issuer/0001178711","role":"Ten percent owner","n_filings":1,"first_seen":"2011-09-23","last_seen":"2011-09-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001096738","name":"EPOCRATES INC","url":"/issuer/0001096738","role":"Other","n_filings":1,"first_seen":"2011-02-07","last_seen":"2011-02-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001356857","name":"Trius Therapeutics Inc","url":"/issuer/0001356857","role":"Other","n_filings":1,"first_seen":"2010-08-10","last_seen":"2010-08-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001053221","name":"METABASIS THERAPEUTICS INC","url":"/issuer/0001053221","role":"Ten percent owner","n_filings":3,"first_seen":"2004-06-23","last_seen":"2008-04-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001371217","name":"EnteroMedics Inc","url":"/issuer/0001371217","role":"Ten percent owner","n_filings":1,"first_seen":"2007-11-19","last_seen":"2007-11-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001293928","retrieved_at":"2026-08-25T18:44:56+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}